抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 | N-(3-(5-chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | 918505-84-7 | C17H14ClF2N3O3S |
| N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-a]吡啶-2-胺 | {[8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]-pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine} | 1257704-57-6 | C24H26N6O2S |
| N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺 | N-(3,5-bistrifluoromethylphenyl)-5-chloro-2-hydroxybenzamide | 978-62-1 | C15H8ClF6NO2 |
| N-[2-甲基-5-[(甲基氨基)甲基]苯基]-4-[(4-苯基喹唑啉-2-基)氨基]苯甲酰胺 | BMS 833923 | 1059734-66-5 | C30H27N5O |
| N-[2-氯-4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N’-(5-甲基-3-异恶唑基)脲 | tivozanib | 475108-18-0 | C22H19ClN4O5 |
| N-[2-氟-4-[[2-[[[4-(4-甲基哌嗪-1-基)哌啶-1-基]羰基]氨基]吡啶-4-基]氧基]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 | N-(2-fluoro-4-{[2-({[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}amino)pyridin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxyamide | 928037-13-2 | C33H37F2N7O4 |
| N-[2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基-5-[[4-(1-甲基-1H-吲哚-3-基)-2-嘧啶基]氨基]苯基]-2-丙烯酰胺 | osimertinib | 1421373-65-0 | C28H33N7O2 |
| N-[2-[4-[(氨基磺酰基)氧基]苯基]乙基]十四酰胺 | Sulfamic acid, 4-(2-((1-oxotetradecyl)amino)ethyl)phenyl ester | 186303-55-9 | C22H38N2O4S |
| N-[2-[3-(1-哌嗪甲基)咪唑并[2,1-B]噻唑-6-基]苯基]-2-喹喔啉甲酰胺盐酸 | SRT1720 | 1001645-58-4 | C25H23N7OS*ClH |
| N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺 | PF-03814735 | 942487-16-3 | C23H25F3N6O2 |
| N-[2-(2-甲基-1H-吲哚-3-基)乙基]-2-噻吩甲酰胺 | N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide | 442632-72-6 | C16H16N2OS |
| N-[1-(环己基甲基)-4-哌啶基]-2-[六氢-4-异丙基-1H-1,4-二氮杂卓-1-基]-6-甲氧基-7-[3-(1-哌啶基)丙氧基]-4-喹唑啉胺 | N-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine | 1320288-19-4 | C37H61N7O2 |
| N-[(4-羟基-1-甲基-7-苯氧基-3-异喹啉)羰基]甘氨酸 | roxadustat | 808118-40-3 | C19H16N2O5 |
| N-[(4-氟苯基)甲基1,6-二氢-5-羟基-1-甲基-6-氧代-2-(四氢-1,1-二氧-2H-1,2-噻嗪-2-基)-4-嘧啶甲酰胺 | BMS-707035 | 729607-74-3 | C17H19FN4O5S |
| N-[(4-乙酰氨基苯基)硫代氨基甲酰]-4-(2-甲基-2-丙基)苯甲酰胺 | tenovin-1 | 380315-80-0 | C20H23N3O2S |
| N-[(3Z)-2-氧代-3-[苯基-[4-(哌啶-1-甲基)苯胺]亚甲基]-1H-吲哚-5-基]乙烷磺酰胺 | hesperadin | 422513-13-1 | C29H32N4O3S |
| N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺 | PD0325901 | 391210-10-9 | C16H14F3IN2O4 |
| N-[(2R)-1,4-二恶烷-2-基甲基]-N-甲基-N'-[3-(1-甲基-1H-吡唑-4-基)-5-氧代-5H-苯并[4,5]环庚并[1,2-b]吡啶-7-基]硫酸二酰胺 | MK-2461 | 917879-39-1 | C24H25N5O5S |
| N-[(1,2-二氢-4,6-二甲基-2-氧代-3-吡啶基)甲基]-5-[乙基(四氢-2H-吡喃-4-基)氨基]-4-甲基-4'-(4-吗啉基甲基)-[1,1'-联苯]-3-甲酰胺 | tazemetostat | 1403254-99-8 | C34H44N4O4 |
| N-3-吡啶-4-[[3-[[5-(三氟甲基)-2-吡啶]氧基]苯基]甲基]-1-哌啶羧酰胺 | Torin1 | 1222998-36-8 | C35H28F3N5O2 |
| N-(叔丁酯-三聚乙二醇)-N-双-(二聚乙二醇-羟基) | N-(Boc-PEG3)-N-bis(PEG2-alcohol) | 2055042-60-7 | C25H52N2O11 |
| N-({1-[(4-氯苯基)氨基]-1-氧代-2-丙基}氧基)-3,5-二(三氟甲基)苯甲酰胺 | n-(2-(4-Chloroanilino)-1-methyl-2-oxoethoxy)-3,5-bis(trifluoromethyl)benzamide | 285986-88-1 | C18H13ClF6N2O3 |
| N-(6-苯甲酰基-1H-苯并咪唑-2-基)-2-(1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶基)-4-噻唑羧酰胺 | N-(6-benzoyl-1H-benzimidazol-2-yl)-2-(1-thieno[3,2-d]pyrimidin-4-yl-4-piperidinyl)-4-thiazolecarboxamide | 913822-46-5 | C29H23N7O2S2 |
| N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺 | GSK429286A | 864082-47-3 | C21H16F4N4O2 |
| N-(6-(4-(2-((4-((4-甲基哌嗪-1-基)甲基)-3-(三氟甲基)苯基)氨基)-2-氧乙基)苯氧基)嘧啶-4-基)环丙酰胺 | N-(6-(4-(2-((4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)amino)-2-oxoethyl)phenoxy)pyrimidin-4-yl)cyclopropanecarboxamide | 1421227-53-3 | C29H31F3N6O3 |
| N-(6,8-二氟-2-甲基-4-喹啉)-N-[4-(二甲氨基)苯基]尿素 | SB 408124 | 288150-92-5 | C19H18F2N4O |
| N-(5-苯基-2-吡啶基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2-d]嘧啶-2-基)硫基]乙酰胺 | IWP-L6 | 1427782-89-5 | C25H20N4O2S2 |
| N-(5-氯-2-甲氧基苯基)-N'-(2-甲基-4-喹啉基)脲 | PQ401 | 196868-63-0 | C18H16ClN3O2 |
| N-(5-氯-2,4-二甲氧基苯基)-N’-(5-甲基-3-异唑基)脲 | 1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea | 501925-31-1 | C13H14ClN3O4 |
| N-(5-叔丁基-异噁唑-3-基)-N-{4-[7-(2-吗啉-4-基乙氧基)咪唑并[2,1-b][1,3]苯并噻唑-2-基]苯基}脲 | quizartinib | 950769-58-1 | C29H32N6O4S |
| N-(4-碘苯基)-5-硝基呋喃-2-甲酰胺 | N-(4-iodophenyl)-5-nitrofuran-2-carboxamide | 314054-00-7 | C11H7IN2O4 |
| N-(4-甲氧基苄基)-N'-(5-硝基-1,3-噻唑-2-基)脲 | N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea | 487021-52-3 | C12H12N4O4S |
| N-(4-氯苯基)-N-[2,3-二氢-1-甲基-5-(1-甲基乙基)-3-氧代-2-苯基-1H-吡唑-4-基]-脲 | N-(4-chlorophenyl)-N'-[2,3-dihydro-1-methyl-5-(1-methylethyl)-3-oxo-2-phenyl-1H-pyrazol-4-yl]urea | 903895-98-7 | C20H21ClN4O2 |
| N-(4-氯苯基)-1-[3-(2-呋喃基)苯甲酰基]-3-哌啶甲酰胺 | N-(4-chlorophenyl)-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide | 1443437-74-8 | C23H21ClN2O3 |
| N-(4-氯-2-氟苯基)-6,7-二甲氧基-4-喹唑啉胺 | ZM-306416 | 690206-97-4 | C16H13ClFN3O2 |
| N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺 | VX-765 | 273404-37-8 | C24H33ClN4O6 |
| N-(4-氨基-2-甲基-6-喹啉基)-2-[(4-乙基苯氧基)甲基]苯甲酰胺盐酸盐 | JTC 801 | 244218-51-7 | C26H25N3O2*ClH |
| N-(4-([1,2,4]噻唑并[1,5-a]吡啶-7-基氧基)-3-甲基苯基)-6-(5-(((2-(甲基磺酰基)乙基)氨基)甲基)呋喃-2-基)喹唑啉-4-胺 | ARRY380 | 937265-83-3 | C29H27N7O4S |
| N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 | N-(3-methylphenyl)-4-(4-pyridinyl)-1,3-thiazol-2-amine | 315702-99-9 | C15H13N3S |
| N-(3-氰基-4,5,6,7-四氢苯并[b]噻吩-2-基)-1-萘甲酰胺 | JNK Inhibitor IX | 312917-14-9 | C20H16N2OS |
| N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺 | (3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-[(4-methylpiperazin-1-yl)carbonyl]-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxoindoline-5-sulfonamide | 658084-23-2 | C28H30ClN5O4S |
| N-(3-氯苯基)-2-吡啶甲酰胺 | N-(3-chlorophenyl)picolinamide | 61350-00-3 | C12H9ClN2O |
| N-(3-氨基丙基)-3-氯-N-[(1R)-1-[7-氯-3,4-二氢-4-氧代-3-(苯基氨基)-2-喹唑啉基]-3-丁炔-1-基]-2-氟苯甲酰胺 | ARQ 621 | 1095253-39-6 | C28H24Cl2FN5O2 |
| N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 | GNF-5 | 778277-15-9 | C20H17F3N4O3 |
| N-(2-氯苯基)-4-(2-(4-(2-(4-乙基哌嗪-1-基)-2-氧代乙基)苯基氨基)-5-氟嘧啶-4-基氨基)苯甲酰胺 | aurora A inhibitor I | 1158838-45-9 | C31H31ClFN7O2 |
| N-(2,6-二乙基苯基)-4,6-二氢-3-[[4-(4-甲基-1-哌嗪基)苯甲酰基]氨基]吡咯并[3,4-c]吡唑-5(1H)-甲酰胺 | PHA-680632 | 398493-79-3 | C28H35N7O2 |
| N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 | N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide | 677338-12-4 | C18H17N5O3 |
| N-(1,3-苯并二氧戊环-5-基甲基)-4-苯并呋喃并[3,2-d]嘧啶-4-基-1-哌嗪硫代甲酰胺 | Amuvatinib | 850879-09-3 | C23H21N5O3S |
| N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | N-tert-butyl-3-{5-methyl-2-[4-(2-pyrrolidin-1-yl-ethoxy)-phenylamino]-pyrimidin-4-ylamino}-benzenesulfonamide | 936091-26-8 | C27H36N6O3S |
| N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 | N-tert-butyl-3-[(5-methyl-2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide | 936091-14-4 | C26H35N7O2S |